02 January, 2005 |
| 11:18 |
Seasons Greetings |
A. D'Emanuele |
05 January, 2005 |
| 05:59 |
Bio-equivalence study for hormonal products. |
Archana |
09 January, 2005 |
| 09:34 |
Chiral Drugs |
Itfar |
| 12:25 |
Re: Chiral Drugs |
lt09 |
| 14:04 |
Re: Chiral Drugs |
bruce berger |
12 January, 2005 |
| 15:35 |
Re: Chiral Drugs |
Ivanow, Frederic [PRDGB] |
13 January, 2005 |
| 08:12 |
Reanalysis of bioequivalence samples. |
Nisha K R |
15 January, 2005 |
| 07:27 |
Legal clearance for APIs/ FP generics in ANDAs |
Archana |
19 January, 2005 |
| 16:02 |
Manufacture for dose weight proportional strengths |
Pooja |
22 January, 2005 |
| 15:16 |
Guidence for assay limit for Different strengths of same formulation |
himanshu narang |
| 21:18 |
Re: Guidence for assay limit for Different strengths of same formulation |
lt09 |
23 January, 2005 |
| 05:15 |
Re: Guidence for assay limit for Different strengths of same formulation |
lt09 |
24 January, 2005 |
| 06:20 |
Volume of dissolution medium |
Nisha K R |
01 February, 2005 |
| 08:32 |
Veterinary Implant - Dissolution studies |
Tarlok Bola |
02 February, 2005 |
| 07:54 |
Re: Volume of dissolution medium |
Anjali B Narkhede |
| 20:05 |
validated test methods |
Kate Norton |
07 February, 2005 |
| 10:56 |
Global Specifications/Testing of pharmaceutical products |
Nicola Nestor |
| 11:53 |
Re: Global Specifications/Testing of pharmaceutical products |
Jean M Krebs |
11 February, 2005 |
| 11:09 |
Accessing dockets from US Federal register |
Archana |
| 12:20 |
RE: Accessing dockets from US Federal register |
Lassoff, Peter |
14 February, 2005 |
| 18:50 |
RE: Accessing dockets from US Federal register |
cheryl.elkins |
15 February, 2005 |
| 05:19 |
RE: Accessing dockets from US Federal register |
cheryl.elkins |
16 February, 2005 |
| 08:03 |
RE: Accessing dockets from US Federal register |
Peter Geffen |
22 February, 2005 |
| 06:57 |
Bilayer Tablets |
nirav.chokshi |
| 16:36 |
Packaging materials suppliers list |
vardhini kirthivas |
24 February, 2005 |
| 05:13 |
Malaria Test Kits |
agneslee |
01 March, 2005 |
| 09:45 |
Inactive RMs |
Anita |
| 15:08 |
RE: Inactive RMs |
PB Consultancy |
02 March, 2005 |
| 05:39 |
Bioequivalence query |
Anita |
| 14:39 |
RE: Bioequivalence query |
Scott Catron |
03 March, 2005 |
| 06:23 |
Physical parameters of generic product |
Amit |
| 08:14 |
Re: Physical parameters of generic product |
Michael Anisfeld |
| 09:04 |
Re: Physical parameters of generic product |
Marcio.O.Silva |
04 March, 2005 |
| 07:09 |
Re: Physical parameters of generic product |
Nisha K R |
| 09:17 |
Re: Physical parameters of generic product |
Pooja |
| 11:05 |
target weight |
prasanna sagar |
15 March, 2005 |
| 12:43 |
GRAS |
Amit |
| 17:17 |
Excipients for ANDA |
Vimal Patel |
16 March, 2005 |
| 04:40 |
Fw: Excipients for ANDA |
Rashmi |
| 04:41 |
Re: Excipients for ANDA |
P M |
| 04:42 |
Re: GRAS |
P M |
| 11:58 |
Japanese Rules for active ingredients (in English) |
Birthe Arp-Hansen |
| 12:59 |
Re: Japanese Rules for active ingredients (in English) |
Michael Anisfeld |
| 14:19 |
Re: Japanese Rules for active ingredients (in English) |
Louise_Wen |
| 22:10 |
RE: Japanese Rules for active ingredients (in English) |
Globepharm /Anisfeld |
23 March, 2005 |
| 07:21 |
Clinical Labeling |
Barbara Hickok |
| 09:40 |
Re: Clinical Labeling |
Dpcox |
| 20:14 |
Re: Clinical Labeling |
HoroRL |
24 March, 2005 |
| 07:49 |
UK Guide to Good Manufacturing Practice (Orange Guide) |
Brian MATTHEWS |
| 16:23 |
Child Resistant Closures - BS8404 |
Fiona Storey |
29 March, 2005 |
| 16:28 |
RE: Clinical Labeling |
Lassoff, Peter |
04 April, 2005 |
| 16:19 |
recycling of solvents and reagents |
Paul van Zomeren |
06 April, 2005 |
| 11:45 |
Re: Rapporteaur, Co Rappourteur and Centralised procedure |
anju jain |
| 12:55 |
Re: Rapporteaur, Co Rappourteur and Centralised procedure |
mukesh shrivas |
| 12:57 |
Re: Rapporteaur, Co Rappourteur and Centralised procedure |
mona.gogia |
12 April, 2005 |
| 18:03 |
Stability requirements on Application |
Sacha Holder |
| 19:31 |
Re: Stability requirements on Application |
Brian MATTHEWS |
| 20:22 |
RE: Stability requirements on Application |
ramasamy venkatasamy |
13 April, 2005 |
| 18:49 |
RE: Stability requirements on Application |
Lassoff, Peter |
14 April, 2005 |
| 18:45 |
Stability requirements for change in storage conditions. |
Naren |
15 April, 2005 |
| 09:36 |
Re: Stability requirements for change in storage conditions. |
Paul van Zomeren |
| 12:56 |
DMF and COS |
richa dayaramani |
| 17:04 |
Re: DMF and COS |
Paul van Zomeren |
19 April, 2005 |
| 22:03 |
Tests requirements |
Naren |
20 April, 2005 |
| 07:53 |
Re: Tests requirements |
HoroRL |
| 09:43 |
Animal bioequivalence study |
Joseph Kwong |
| 10:22 |
Re: Tests requirements |
P M |
21 April, 2005 |
| 09:29 |
Re: Animal bioequivalence study |
Venkatesh. P |
| 10:41 |
Re: Animal bioequivalence study |
Paul van Zomeren |
25 April, 2005 |
| 23:24 |
residual solvents in finished product |
Kate Gibbon |
28 April, 2005 |
| 15:32 |
Sunset Clause |
Neil Bredge |
02 May, 2005 |
| 22:25 |
Reduce annual stability batches/year |
Naren |
03 May, 2005 |
| 06:29 |
Re: Reduce annual stability batches/year |
Stanley110 |
| 06:30 |
Botanical Drug Substances |
Stanley110 |
| 09:01 |
Re: Botanical Drug Substances |
Paul van Zomeren |
| 15:32 |
Re: Botanical Drug Substances |
himanshu narang |
04 May, 2005 |
| 10:18 |
Dissolution database |
Nisha K R |
| 12:05 |
Re: Dissolution database |
P M |
| 13:03 |
RE: Botanical Drug Substances |
Ketan Agravat |
07 May, 2005 |
| 06:42 |
Excipients testing (EU) |
Tomasz Zawislak |
| 14:57 |
Re: Excipients testing (EU) |
Brian MATTHEWS |
11 May, 2005 |
| 05:54 |
Stress testing for pharmacopoeial products |
Vimal Patel |
| 11:54 |
Re: Stress testing for pharmacopoeial products |
Brian Matthews |
12 May, 2005 |
| 14:25 |
Electronic labels |
Nisha K R |
| 15:00 |
Definition of the "Manufacturer" |
Tomasz Zawislak |
13 May, 2005 |
| 00:30 |
RE: Definition of the "Manufacturer" |
marygavigan |
| 10:47 |
RE: Definition of the "Manufacturer" |
Jóhann M. Lenharðsson |
16 May, 2005 |
| 09:05 |
Para IV |
sachin dangra |
30 May, 2005 |
| 08:49 |
Outsourcing regulatory tasks |
Nestby, P. (Patrizia) |
31 May, 2005 |
| 11:41 |
RE: Outsourcing regulatory tasks |
Lassoff, Peter |
01 June, 2005 |
| 07:02 |
DMF of API not present |
anju jain |
| 08:54 |
Re: DMF of API not present |
lt09 |
| 11:21 |
MSDS |
Bridget Novaes (ISM) |
| 13:21 |
Re: DMF of API not present |
anju jain |
| 13:21 |
Renewal fees in Turkey |
anju jain |
| 19:16 |
Re: DMF of API not present |
Brian MATTHEWS |
02 June, 2005 |
| 06:55 |
Requirements to be an expert. |
Nisha K R |
06 June, 2005 |
| 13:36 |
Retention of ANDA products at manufacturing unit |
Rashmi |
| 15:04 |
Re: Retention of ANDA products at manufacturing unit |
nirav.chokshi |
| 16:11 |
Re: Retention of ANDA products at manufacturing unit |
nirav.chokshi |
